ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 18.57 Delayed Data As of Jan 27 |  -0.09 / -0.48%Today’s Change | 12.24 Today|||52-Week Range 28.06 | +16.65% Year-to-Date |
Latest ACAD News | Press Releases
No recent news for ACADIA Pharmaceuticals Inc.
Today’s Trading
| Previous close | 18.66 |
| Today’s open | 18.71 |
| Day’s range | 18.39 - 18.79 |
| Volume | 28,073 |
| Average volume (3 months) | 1,298,712 |
| Market cap | $3.1B |
Data as of 4:00pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +41.56% |
| Earnings growth (this year) | -25.31% |
| Earnings growth (next 5 years) | +34.14% |
| Revenue growth (last year) | +9.60% |
| P/E ratio | NM |
| Price/Sales | 7.74 |
| Price/Book | 5.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BHCValeant Pharmaceutic... | -0.02 | -0.24% |
| MRTXMirati Therapeutics ... | +2.04 | +4.00% |
| RAREUltragenyx Pharmaceu... | 0.00 | 0.00% |
| INSMInsmed Inc | +0.23 | +1.07% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | February 27, 2023 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $484.1M |
| Annual profit (last year) | -$167.9M |
| Net profit margin | -34.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
